Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PENTASA
- Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
- Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
- Mercaptopurine Therapy in Ulcerative Colitis
- The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
- Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
- QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
- An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
- Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
- Correlation of Mesalamine Pharmacokinetics With Local Availability
- Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
- Predicting Response to Standardized Pediatric Colitis Therapy
- Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
- Targeting Oxidative Stress in Chronic Beryllium Disease
- Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)
- A Study With Pentasa in Patients With Active Crohn's Disease
- Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.
- Canadian Active & Maintenance Modified Pentasa Study
- A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
- The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
- Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
- The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
- Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
- Monoclonal Antibody Treatment of Crohn's Disease
Clinical trials list
click for details